Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Oxford Molecular Group and Alizyme begin research collaboration

June 28, 1996

Boston Life Science holds patent rights to C-Maf

June 28, 1996

3-D IMP dehydrogenase structure solved

June 28, 1996

Gensia receives first payment from Pfizer

June 28, 1996

Ciba-Geigy and Synaptic extend collaboration

June 28, 1996

Competitive Technologies and Mount Sinai School of Medicine sign agreement

June 21, 1996

Cheung Laboratories and MIT reach marketing agreement

June 21, 1996

Zeneca to utilize Incyte database and technologies

June 21, 1996

RPR Gencell and IntraImmune Therapies enter drug development agreement

June 21, 1996

Megabios issued worldwide license to lipid-DNA complexes

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...